Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus tiagabine crossover study in adults with social anxiety disorder
ACTRN12609000091202Phase 3Completed
- Sponsor
- Maria Urbano, M.D.
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin and tiagabine in Social Anxiety Disorder (SAD) (2 arms), sponsored by Maria Urbano, M.D. Primary endpoint: Liebowitz Social Anxiety Scale. Started May 2003; status: completed.
02
Drugs
gabapentintiagabine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on ACTRN12609000091202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000091202.